Links and Resources
On This Page
TATFAR Reports and Publications
Progress Reports
- 2021 TATFAR Progress Report [PDF – 47 Pages]
- 2014 TATFAR Progress Report [PDF – 86 Pages]
- 2011 Report [PDF – 47 Pages]
Publications
- 2019 Targets for the reduction of Antibiotic Use in humans
- 2017 Pull Incentives for Antibacterial Drug Development
- 2016 Economic Incentives for Antimicrobial Therapy Development
- 2015 Report on the modified Delphi process for common structure and process indicators for hospital antimicrobial stewardship programs [PDF – 67 Pages]
- Using Available Data Sources at the Country Level to Track Antibiotic Use [PDF – 10 Pages]
Video Clips
Historical Documents
Key Publications
Antibiotic Resistance Action Plans
- Canada: Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action
- European Union: A European One Health Action Plan against Antimicrobial Resistance (AMR) [PDF – 24 Pages]
- Norway: Norwegian National Strategy Against Antibiotic Resistance 2015-2020
- United States: United States National Action Plan for Combating Antibiotic-Resistant Bacteria
Center for Disease Control and Prevention
- Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report)
- Initiatives for Addressing Antimicrobial Resistance in the Environment are two corresponding reports published in 2018 providing an overview of the current evidence base and ongoing knowledge gaps around antibiotic resistant in the environment (e.g., water, soil) and the potential effect on human health.
- Reports on Antibiotic Use in the United States: Progress and Opportunities
European Centre for Disease Prevention and Control
- Will COVID-19 have an impact on AMR?
- Cross-border spread of blaNDM-1– and blaOXA-48-positive Klebsiella pneumoniae: A European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
- ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2017 [PDF – 135 Pages]
- ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2015 [PDF – 114 Pages]
- Antimicrobial Resistance in Europe, ECDC, 2011
- The Bacterial Challenge: Time to React, ECDC, 2009
European Commission
- Research, Innovation, and Policy: An Alliance Combating AMR, 2019
- A European One Health Action Plan against Antimicrobial Resistance, 2017 [PDF – 24 Pages]
- Progress report on the Action plan against the rising threats from Antimicrobial
Resistance, 2015 [PDF – 47 Pages] - Action plan against the rising threats from Antimicrobial Resistance, 2011 [PDF – 17 Pages]
European Food Safety Authority
- INNUENDO: A Cross‐sectoral Platform for the Integration of Genomics in the Surveillance of Food‐borne Pathogens (2018)
- Final Report of ENGAGE ‐ Establishing Next Generation Sequencing Ability for Genomic Analysis in Europe (2018)
- Outcome of EC/EFSA Questionnaire on use of Whole Genome Sequencing for Food‐ and Waterborne Pathogens Isolated from Animals, Food, Feed, and Related Environmental Samples (2018)
- Comparative Genomics of Quinolone‐resistant and Susceptible Campylobacter Jejuni of Poultry Origin from major Poultry Producing European Countries (2018)
- ECDC, EFSA, EMA Joint Scientific Opinion on a List of Outcome Indicators as Regards Surveillance of AMR and Antimicrobial Consumption in Humans and Food-producing Animals (2017)
- ECDC, EFSA, EMA Second Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of AMR in Bacteria from Humans and Food-producing Animals (2017)
- Risk for the Development of AMR due to Feeding of Calves with Milk Containing Residues of Antibiotics (2017)
- EMA, EFSA Joint Scientific Opinion on Measures to Reduce the need to use Antimicrobial Agents in Animal Husbandry in the European Union, and the Resulting Impacts on Food Safety (2016)
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2016
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2015
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2014
- The EU Summary Report on AMR in Zoonotic Indicator Bacteria from Humans, Animals, and Food in 2013
- ECDC, EFSA, EMA First Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of AMR in Bacteria from Humans and Food-producing Animals (2015)
European Medicines Agency
- Tenth European Surveillance of Veterinary Antimicrobial Consumption Report: Sales of veterinary antimicrobial agents in 31 European countries, 2018 [PDF – 104 Pages]
- Report on the event “Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem” [PDF – 4 Pages]
Public Health Agency of Canada
U.S. Food and Drug Administration
- Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs [PDF – 17 Pages]
- FDA Holds Virtual Public Meeting to Discuss Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial Animal Drugs
- Guidance for Industry #209, The Judicious Use of Medically Important Antibiotics in Food Producing Animals, FDA, 2012 [PDF – 26 Pages]
U.S. National Institute of Allergy and Infectious Diseases
Antimicrobial Resistance Funding
Find funding opportunities related to AMR on the agency or organization website or reach out to a contact listed for more information.
| Organization | Contact | Funding Opportunities |
|---|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Mark Albrecht, Mark.Albrecht@hhs.gov | |
| Canadian Institutes of Health Research | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | |
| CARB-X | ||
| CDC | Rachael Aubert, vrl7@cdc.gov | |
| Directorate-General for Research and Innovation | Arjon van Hengel, Adrianus.Van-Hengel@ec.europa.eu | |
| Innovative Medicines Initiative | ||
| Joint Programming Initiative on AMR | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | |
| National Institute of Health | Dennis Dixon dmdixon@niaid.nih.gov | |
| Norwegian Institute of Public Health | Christine Årdal, christine.ardal@fhi.no | |
| U.S. Department of Agriculture | Kathe Bjork, kathe.e.bjork@usda.gov |
Page last reviewed: June 7, 2021